Mitoimmune Therapeutics

About:

Mito Immune Therapeutics is a drug research and development biotech company.

Website: https://mitoimmune.com

Top Investors: KB Investment, Korea Development Bank, IMM Investment, Aju IB Investment, SL Investment

Description:

Total Funding Amount:

39.5B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2018-01-01

Contact Email:

jaeuk.lee(AT)mitoimmune.com

Founders:

Soon ha Kim

Number of Employees:

11-50

Last Funding Date:

2021-02-26

IPO Status:

Private

Industries: